Induction therapy with infliximab effective against severe Behçet's syndrome Jacinthlyn Sylvia19 Nov 2024 8:45 PM ISTA recent groundbreaking phase 2 trial compared the induction therapies for severe Behçet's syndrome revealed that infliximab is both effective and...
Anti-inflammatory drugs may prevent death but fail to speed up recovery in COVID-19 patients Aditi27 July 2023 11:15 AM ISTAn Original Investigation published on July 10, 2023, entitled, "Abatacept, Cenicriviroc, or Infliximab for Treatment of Adults Hospitalized With...
Switching to IV golimumab from IV infliximab improves disease activity in RA Medha Baranwal5 April 2022 9:00 AM ISTUSA: Switching to IV-golimumab from IV-infliximab is beneficial in patients with rheumatoid arthritis (RA) as it may improve drug tolerance and...
Steroid-free endoscopic remission not linked to less disease progression in Crohn's Disease: Study Medical Dialogues Editorial Team24 Jan 2022 9:00 AM ISTFrance: Achieving prolonged clinical remission off steroids with full endoscopic remission in patients with early Crohn's disease (CD) was not related...
Steroids improve liver test abnormalities in infliximab-induced liver injury: Study Medha Baranwal5 Jan 2022 9:00 AM ISTIceland: Liver injury and liver inflammation is a rare side effect of infliximab, a biological medicine used to treat multiple inflammatory diseases....
Serum oncostatin M, a potential biomarker of disease activity and infliximab response in IBD patients: Study MD Editorial Team2 Dec 2021 10:30 AM ISTChina: In a new study conducted by Ying Cao and the team, it was shown that chemiluminescence immunoassay (CLIA) newly created technique has a lot of...
Use of some biologics increase risk of serious infections in psoriasis patients: JAMA MD Editorial Team14 Oct 2021 9:00 AM ISTFrance: A new study by Laetitia Penso and colleagues reported that the risk of serious infections is increased in new users of infliximab and...
Pfizer gets CDSCO panel marketing authorization for Infliximab Medical Dialogues Team15 Sept 2021 1:52 PM ISTNew Delhi: Granting permission for a local Phase III clinical trial waver, the Subject Expert Committee (SEC) of the Central Drugs Standard Control...
Monitor IBD patients on infliximab carefully after COVD-19 vaccination Hina Zahid24 March 2021 10:27 AM ISTCareful monitoring of patients treated with infliximab needed after COVID jab. Infliximab, a powerful biologic that is used to treat inflammatory...
Infliximab bests conventional treatment to achieve Crohn's disease remission in kids: BMJ Medha Baranwal21 Jan 2021 6:00 PM ISTNetherlands: First-line infliximab (FL-IFX) is more effective than conventional treatment in achieving and maintaining remission in pediatric patients...
COVID-19 Drug Trial: Arthritis, Cancer drug Namiluma, Infliximab tested in UK Ruchika Sharma11 Jun 2020 9:15 AM ISTIzana Bioscience's Namiluma, a monoclonal antibody already in late-stage tests to treat rheumatoid arthritis and an inflammatory disease called...
